MECHANISM OF CARCINOGENESIS OF DIBENZ ACRIDINE
二苯吖啶的致癌机制
基本信息
- 批准号:3250572
- 负责人:
- 金额:$ 12.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-08-01 至 1992-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Polycyclic aromatic hydrocarbons (PAHs) and their aza-analogs (aza-
PAHs) are ubiquitous environmental carcinogens. PAHs are known to
require metabolic activation to their bay-region diol epoxides for
producing their carcinogenic effects, but only recent evidence has
implicated the bay-region diol epoxides with R,S,S,R absolute
configuration as the ultimate carcinogens of several PAHs including
benzo(a)pyrene (BP). However, the matter is not yet settled.
Recent studies have indicated that many potentially carcinogenic
PAHs and aza-PAHs may differ from BP in two aspects: (i) the
absolute configuration of the bay-region diol epoxide of certain
PAHs, such as dibenz(a,j)anthracene and its 14-aza-analog
dibenz(c,h)acridine, may not play a major a major role in
determining their tumorigenicity and (ii) certain PAHs, such as
dibenz(a,h)anthracene, 7-methylbenz(a)anthracene and 7,12-
dimethylbenz(a)anthracene may not be metabolized to their respec-
tive R,S,S,R -bay-region diol epoxides with a high degree of
stereoselectivity. In both the aspects, we believe that steric
factors such as steric constraint in the bay-region, molecular
shape and/or the presence of certain substituents (e.g. methyl or
aza) play a significant role. In order to better understand the
molecular factors (including steric ones) that may influence (i)
the tumorigenic and mutagenic activities of the bay-region diol
epoxide enantiomers, and (ii) the stereoselectivity of the enzymes
involved in the metabolic activation of PAHs and aza-PAHs, we
propose to study dibenz(a,h)acridine DB(a,h)ACR as a model
compound, and compare our results with those obtained previously
with other PAHs and aza-PAHs. DB(a,h)ACR differs from previously
studied dibenz(c,h)-acridine in its molecular shape and in the
degree of steric constraint in the bay-region.
The specific aims of the proposed research are: (i) to synthesize
enantiomerically pure DB(a,h)ACR-10,11-diols and their epoxides,
(ii) to determine the stereoselectivity involved in the metabolism
of DB(a,h)ACR and its enantiomerically pure DB(a,h)ACR-10,11-diols
to DB(a,h)ACR-10,11-diols and DB(a,h)ACR-10,11-diol-8,9-epoxides,
respectively by liver microsomes from control, 3-MC-treated and PB-
treated rats, and by a purified and reconstituted cytochrome P-450c
system, (iii) to assess the mutagenic and tumorigenic activities
of DB(a,h)ACR and its enantiomerically pure dihydrodiol and diol
epoxide derivatives, and (iv) to evaluate the stereochemical model
proposed by Jerina et al. for the PAH binding site of cytochrome
P-450c.
多环芳烃(PAHs)及其氮杂类似物(aza-analogs)
多环芳烃是普遍存在的环境致癌物。 已知多环芳烃
需要代谢活化其海湾区二醇环氧化物,
产生致癌作用,但只有最近的证据表明,
暗示海湾区二醇环氧化物与R,S,S,R绝对
作为几种多环芳烃的最终致癌物,
苯并(a)芘(BP)。 然而,这件事还没有解决。
最近的研究表明,许多潜在的致癌物质
多环芳烃和氮杂多环芳烃可能在两个方面与BP不同:(i)
某些海湾区域二醇环氧化物的绝对构型
多环芳烃,如二苯并(a,j)蒽及其14-氮杂-类似物
二苯并(c,h)吖啶,可能不会发挥主要作用,
确定其致瘤性和(ii)某些多环芳烃,如
二苯并(a,h)蒽、7-甲基苯并(a)蒽和7,12-
二甲基苯(a)蒽可能不会代谢成它们各自的
具有高度的环氧化度的活性R,S,S,R -海湾区二醇环氧化物,
立体选择性 在这两个方面,我们认为,
诸如在海湾区域中的空间约束、分子
形状和/或某些取代基(例如甲基或
#21453;起重要作用。 为了更好地理解
可能影响(i)的分子因素(包括空间因素)
海湾二醇的致瘤和致突变活性
环氧化物对映体,和(ii)酶的立体选择性
参与多环芳烃和氮杂多环芳烃的代谢活化,我们
建议以二苯并(a,h)吖啶DB(a,h)ACR为模型化合物进行研究
化合物,并将我们的结果与以前获得的结果进行比较
与其他多环芳烃和氮杂多环芳烃。 DB(a,h)ACR与以前不同
研究了二苯并(c,h)-吖啶在其分子形状和
在海湾地区的空间限制程度。
拟议研究的具体目标是:(一)综合
对映体纯的DB(a,h)ACR-10,11-二醇及其环氧化物,
(ii)以确定代谢中涉及的立体选择性
DB(a,h)ACR及其对映体纯的DB(a,h)ACR-10,11-二醇
DB(a,h)ACR-10,11-二醇和DB(a,h)ACR-10,11-二醇-8,9-环氧化物,
对照组、3-MC处理组和PB处理组的肝微粒体中,
处理的大鼠,并通过纯化和重建的细胞色素P-450 c
系统,(iii)评估致突变和致肿瘤活性
DB(a,h)ACR及其对映体纯的二氢二醇和二醇的
环氧化物衍生物,和(iv)评价立体化学模型
由Jerina等人提出,用于细胞色素的PAH结合位点
P-450 c。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUBODH KUMAR其他文献
SUBODH KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUBODH KUMAR', 18)}}的其他基金
MUTAGENESIS/CARCINOGENESIS OF DIBENZ(A,C)ANTHRACENE
二苯(A,C)蒽的诱变/致癌作用
- 批准号:
3251485 - 财政年份:1985
- 资助金额:
$ 12.04万 - 项目类别:
MUTAGENESIS/CARCINOGENESIS OF DIBENZ(A,C)ANTHRACENE
二苯(A,C)蒽的诱变/致癌作用
- 批准号:
3251481 - 财政年份:1985
- 资助金额:
$ 12.04万 - 项目类别:
MUTAGENESIS/CARCINOGENESIS OF DIBENZ(A,C)ANTHRACENE
二苯(A,C)蒽的诱变/致癌作用
- 批准号:
3251486 - 财政年份:1985
- 资助金额:
$ 12.04万 - 项目类别: